Continuous subcutaneous insulin infusion and multiple dose of insulin regimen display similar patterns of blood glucose excursions in pediatric type 1 diabetes

Ramin Alemzadeh, Paola Palma-Sisto, E. A. Parton, M. K. Holzum

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Background: Continuous subcutaneous insulin infusion (CSII) is believed to decrease glycemic variability and clinical hypoglycemia compared with the multiple daily insulin (MDI) regimen. To compare the indices of glycemic instability between CSII and MDI, we analyzed the continuous glucose monitoring system (CGMS®) (Medtronic MiniMed, Northridge, CA) profiles of a group of children with type 1 diabetes mellitus with history of frequent blood glucose (BG) fluctuations and hypoglycemia. Patients and Methods: Data from 14 (nine girls, five boys) patients (3.9-16.8 years old) on CSII and 14 age- and sex-matched (nine girls, five boys) patients (3.9-16.0 years old) on MDI with similar glycemic control (hemoglobin A1c: 7.9 ± 1.0% vs. 7.9 ± 1.5%) and body mass index (BMI) (20.1 ± 4.3 vs. 19.9 ± 4.1 kg/m2) were evaluated by the CGMS. Mean BG (MBG), absolute means of daily differences (MODD), mean amplitude of glycemic excursion (MAGE), and number of hypoglycemic events (BG <60 mg/dL) for 48 h were calculated. Results: The MBG, MODD, MAGE, and number and mean duration of hypoglycemia events in the CSII group were similar to those in the MDI group. The MAGE had an inverse correlation with age (CSII: r2 = 0.52, P < 0.003; MDI: r2 = 0.29, P < 0.04) and BMI (CSII: r2 = 0.38, P < 0.02; MDI: r2 = 0.71, P < 0.0002). However, there was a positive relationship between MAGE and bolus:basal insulin ratio in the CSII (r 2 = 0.28, P < 0.05) and MDI (r2 = 0.33, P < 0.03) groups. Also, the MAGE had a positive correlation with frequency of hypoglycemic events in the CSII (r2 = 0.44, P < 0.01) and MDI (r2 = 0.35, P < 0.03) groups. Conclusions: The CSII and MDI regimens in children and adolescents with comparable glycemic control displayed similar patterns of glycemic excursions, implying that factors influencing glycemic instability in pediatric type 1 diabetes mellitus appear to be independent of treatment modality.

Original languageEnglish (US)
Pages (from-to)587-596
Number of pages10
JournalDiabetes Technology and Therapeutics
Volume7
Issue number4
DOIs
StatePublished - Aug 1 2005
Externally publishedYes

Fingerprint

Subcutaneous Infusions
Type 1 Diabetes Mellitus
Blood Glucose
Insulin
Pediatrics
Hypoglycemia
Hypoglycemic Agents
Body Mass Index
Glycemic Index
Glucose

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology
  • Medical Laboratory Technology

Cite this

Continuous subcutaneous insulin infusion and multiple dose of insulin regimen display similar patterns of blood glucose excursions in pediatric type 1 diabetes. / Alemzadeh, Ramin; Palma-Sisto, Paola; Parton, E. A.; Holzum, M. K.

In: Diabetes Technology and Therapeutics, Vol. 7, No. 4, 01.08.2005, p. 587-596.

Research output: Contribution to journalArticle

@article{a8835941fa634adba080ca6a5926bb64,
title = "Continuous subcutaneous insulin infusion and multiple dose of insulin regimen display similar patterns of blood glucose excursions in pediatric type 1 diabetes",
abstract = "Background: Continuous subcutaneous insulin infusion (CSII) is believed to decrease glycemic variability and clinical hypoglycemia compared with the multiple daily insulin (MDI) regimen. To compare the indices of glycemic instability between CSII and MDI, we analyzed the continuous glucose monitoring system (CGMS{\circledR}) (Medtronic MiniMed, Northridge, CA) profiles of a group of children with type 1 diabetes mellitus with history of frequent blood glucose (BG) fluctuations and hypoglycemia. Patients and Methods: Data from 14 (nine girls, five boys) patients (3.9-16.8 years old) on CSII and 14 age- and sex-matched (nine girls, five boys) patients (3.9-16.0 years old) on MDI with similar glycemic control (hemoglobin A1c: 7.9 ± 1.0{\%} vs. 7.9 ± 1.5{\%}) and body mass index (BMI) (20.1 ± 4.3 vs. 19.9 ± 4.1 kg/m2) were evaluated by the CGMS. Mean BG (MBG), absolute means of daily differences (MODD), mean amplitude of glycemic excursion (MAGE), and number of hypoglycemic events (BG <60 mg/dL) for 48 h were calculated. Results: The MBG, MODD, MAGE, and number and mean duration of hypoglycemia events in the CSII group were similar to those in the MDI group. The MAGE had an inverse correlation with age (CSII: r2 = 0.52, P < 0.003; MDI: r2 = 0.29, P < 0.04) and BMI (CSII: r2 = 0.38, P < 0.02; MDI: r2 = 0.71, P < 0.0002). However, there was a positive relationship between MAGE and bolus:basal insulin ratio in the CSII (r 2 = 0.28, P < 0.05) and MDI (r2 = 0.33, P < 0.03) groups. Also, the MAGE had a positive correlation with frequency of hypoglycemic events in the CSII (r2 = 0.44, P < 0.01) and MDI (r2 = 0.35, P < 0.03) groups. Conclusions: The CSII and MDI regimens in children and adolescents with comparable glycemic control displayed similar patterns of glycemic excursions, implying that factors influencing glycemic instability in pediatric type 1 diabetes mellitus appear to be independent of treatment modality.",
author = "Ramin Alemzadeh and Paola Palma-Sisto and Parton, {E. A.} and Holzum, {M. K.}",
year = "2005",
month = "8",
day = "1",
doi = "10.1089/dia.2005.7.587",
language = "English (US)",
volume = "7",
pages = "587--596",
journal = "Diabetes Technology and Therapeutics",
issn = "1520-9156",
publisher = "Mary Ann Liebert Inc.",
number = "4",

}

TY - JOUR

T1 - Continuous subcutaneous insulin infusion and multiple dose of insulin regimen display similar patterns of blood glucose excursions in pediatric type 1 diabetes

AU - Alemzadeh, Ramin

AU - Palma-Sisto, Paola

AU - Parton, E. A.

AU - Holzum, M. K.

PY - 2005/8/1

Y1 - 2005/8/1

N2 - Background: Continuous subcutaneous insulin infusion (CSII) is believed to decrease glycemic variability and clinical hypoglycemia compared with the multiple daily insulin (MDI) regimen. To compare the indices of glycemic instability between CSII and MDI, we analyzed the continuous glucose monitoring system (CGMS®) (Medtronic MiniMed, Northridge, CA) profiles of a group of children with type 1 diabetes mellitus with history of frequent blood glucose (BG) fluctuations and hypoglycemia. Patients and Methods: Data from 14 (nine girls, five boys) patients (3.9-16.8 years old) on CSII and 14 age- and sex-matched (nine girls, five boys) patients (3.9-16.0 years old) on MDI with similar glycemic control (hemoglobin A1c: 7.9 ± 1.0% vs. 7.9 ± 1.5%) and body mass index (BMI) (20.1 ± 4.3 vs. 19.9 ± 4.1 kg/m2) were evaluated by the CGMS. Mean BG (MBG), absolute means of daily differences (MODD), mean amplitude of glycemic excursion (MAGE), and number of hypoglycemic events (BG <60 mg/dL) for 48 h were calculated. Results: The MBG, MODD, MAGE, and number and mean duration of hypoglycemia events in the CSII group were similar to those in the MDI group. The MAGE had an inverse correlation with age (CSII: r2 = 0.52, P < 0.003; MDI: r2 = 0.29, P < 0.04) and BMI (CSII: r2 = 0.38, P < 0.02; MDI: r2 = 0.71, P < 0.0002). However, there was a positive relationship between MAGE and bolus:basal insulin ratio in the CSII (r 2 = 0.28, P < 0.05) and MDI (r2 = 0.33, P < 0.03) groups. Also, the MAGE had a positive correlation with frequency of hypoglycemic events in the CSII (r2 = 0.44, P < 0.01) and MDI (r2 = 0.35, P < 0.03) groups. Conclusions: The CSII and MDI regimens in children and adolescents with comparable glycemic control displayed similar patterns of glycemic excursions, implying that factors influencing glycemic instability in pediatric type 1 diabetes mellitus appear to be independent of treatment modality.

AB - Background: Continuous subcutaneous insulin infusion (CSII) is believed to decrease glycemic variability and clinical hypoglycemia compared with the multiple daily insulin (MDI) regimen. To compare the indices of glycemic instability between CSII and MDI, we analyzed the continuous glucose monitoring system (CGMS®) (Medtronic MiniMed, Northridge, CA) profiles of a group of children with type 1 diabetes mellitus with history of frequent blood glucose (BG) fluctuations and hypoglycemia. Patients and Methods: Data from 14 (nine girls, five boys) patients (3.9-16.8 years old) on CSII and 14 age- and sex-matched (nine girls, five boys) patients (3.9-16.0 years old) on MDI with similar glycemic control (hemoglobin A1c: 7.9 ± 1.0% vs. 7.9 ± 1.5%) and body mass index (BMI) (20.1 ± 4.3 vs. 19.9 ± 4.1 kg/m2) were evaluated by the CGMS. Mean BG (MBG), absolute means of daily differences (MODD), mean amplitude of glycemic excursion (MAGE), and number of hypoglycemic events (BG <60 mg/dL) for 48 h were calculated. Results: The MBG, MODD, MAGE, and number and mean duration of hypoglycemia events in the CSII group were similar to those in the MDI group. The MAGE had an inverse correlation with age (CSII: r2 = 0.52, P < 0.003; MDI: r2 = 0.29, P < 0.04) and BMI (CSII: r2 = 0.38, P < 0.02; MDI: r2 = 0.71, P < 0.0002). However, there was a positive relationship between MAGE and bolus:basal insulin ratio in the CSII (r 2 = 0.28, P < 0.05) and MDI (r2 = 0.33, P < 0.03) groups. Also, the MAGE had a positive correlation with frequency of hypoglycemic events in the CSII (r2 = 0.44, P < 0.01) and MDI (r2 = 0.35, P < 0.03) groups. Conclusions: The CSII and MDI regimens in children and adolescents with comparable glycemic control displayed similar patterns of glycemic excursions, implying that factors influencing glycemic instability in pediatric type 1 diabetes mellitus appear to be independent of treatment modality.

UR - http://www.scopus.com/inward/record.url?scp=23944524361&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23944524361&partnerID=8YFLogxK

U2 - 10.1089/dia.2005.7.587

DO - 10.1089/dia.2005.7.587

M3 - Article

VL - 7

SP - 587

EP - 596

JO - Diabetes Technology and Therapeutics

JF - Diabetes Technology and Therapeutics

SN - 1520-9156

IS - 4

ER -